pharmacodiagnostic test (PDx)

	Next higher product group	clinical test_other

Record changed: 2023-07-10

Picture Berlin Partner HealthCapital LSR Personalized Medicine 650x200px

More documents for pharmacodiagnostic test (PDx)

[1] Agilent Technologies Inc.. (7/23/26). "Press Release: Agilent Receives EU Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma". Santa Clara, CA....
[2] Agilent Technologies Inc.. (7/14/26). "Press Release: Agilent Receives FDA Approval for PD-L1 IHC 28-8 pharmDx in Esophageal Squamous Cell Carcinoma (ESCC), Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinoma". Santa Clara, CA....
[3] Agilent Technologies Inc.. (2/11/26). "Press Release: Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC)". Santa Clara, CA....
[4] Agilent Technologies Inc.. (12/10/24). "Press Release: Agilent Companion Diagnostic Assay PD-L1 IHC 28-8 pharmDx Receives European IVDR Certification". Santa Clara, CA....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com